This book chapter advances SDG 3 and 5 by explaining how women have an increased risk of certain chronic autoimmune inflammatory disorders (CIDs). All aspects of the heart’s structure and function may be affected by the autoimmune disease.
This book chapter addresses SDG 3 and 5 by describing specialized cardiovascular care for women, delivered in “women’s heart programs” (WHPs) focus on the cardiovascular needs of women. This chapter reviews the historical background leading to their development, their structure and specialized areas of focus including referral criteria for unique cardiovascular disease (CVD) risk factors in women, and CVD disorders resulting in acute coronary syndromes (ACS) with pathophysiologies seen exclusively, and/or more commonly in women.
Elsevier,
Sex Differences in Cardiac Diseases, Pathophysiology, Presentation, Diagnosis and Management, 2021, Pages 3-6
This chapter advances goals 3 and 5 by outlining the history and progress of women’s inclusion in cardiovascular clinical trials.
Elsevier,
Functional Foods and Nutraceuticals in Metabolic and Non-communicable Diseases, 2022, pp 707-723
This chapter aligns with Goal 14: Life Below Water and Goal 3: Good Health and Wellbeing by highlighting some of the many beneficial nutritional and pharmaceutical applications of marine nutraceuticals.
This chapter advances SDGs 3 and 11 by covering the latest advances in biosensors, which play an innovative role in biomedical applications and improving healthcare. Additionally, the focus is on biosensors derived from natural polysaccharides, i.e. sustainable, bio-based materials.
This book chapter advances SDG 3 by explaining how sex steroids (hormones), through their interactions with the sex steroid receptors present in the heart and vasculature, and their metabolic effects, play a vital role in cardiovascular (CV) health.
This book chapter advances SDG 3 by explaining how peripartum cardiomyopathy (PPCM) is a significant cause of pregnancy-associated morbidity and mortality.
This book chapter advances SDG 3 by explaining how there are many strategies that have been implemented to increase the transplant donor pool, yet the gap between the demand and the offer remains too wide and, as a consequence, the number of patients dying on the waiting list keeps rising.
This book chapter advances SDG 3 by explaining how many scientists share the conviction that human stem cell technology and greater understanding of stem cell biology will in the coming decades fulfill much of its promise and revolutionise medicine as we know it today, improving patient care without past precedent.
This book chapter advances SDG 3 by explaining how the role of biotechnology as a forerunner in the pathway of revolution of human lives has been promising in the recent past. The achievements of biotechnology in the bio-medical front encompass various products like novel vaccines, diagnostic devices, and novel therapeutic strategies.
